Recent genetic data that strongly suggest inflammation to play a role in AD risk have re‐invigorated the investigations of the role of APOE in neuroinflammation and how this contributes to disease 8; and there are emerging data suggesting that APOE may also influence tau‐mediated neurodegeneration 9. Here, MAPT is linked to Alzheimer disease.